Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma

International Journal of Molecular Medicine

Volumn 34, Issue 1, 2014, Pages 205-212

  Yi, Bin ^a   Hu, You ^a   Qin, Gongzhao ^b   Gu, Wen ^a   Zhu, Xinguo ^a   He, Songbing ^a,c   Zhou, Jian ^a   Li, Dechun ^a  

^a SOOCHOW UNIVERSITY   (China)

^b SUZHOU MUNICIPAL HOSPITAL   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Invasion; Matrix metalloproteinase 2; Metastasis; Pancreatic carcinoma; Rho GDP dissociation inhibitor 2

Indexed keywords

GELATINASE A; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 2; SMALL INTERFERING RNA; ARHGDIB PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN;

ADULT; ARTICLE; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR INVASION; AGED; ANTAGONISTS AND INHIBITORS; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; PANCREATIC NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AGED; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR BETA; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84902678752     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1765     Document Type: Article

References (31)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics. CA Cancer J Clin 62: 10-29, 2012.
2. Vincent A, Herman J, Schulick R, Hruban RH and Goggins M: Pancreatic cancer. Lancet 378: 607-620, 2011.
3. Dai H, Li R, Wheeler T, et al: Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach. Hum Pathol 38: 299-307, 2007. (Pubitemid 46096556)
4. Kleeff J, Beckhove P, Esposito I, et al: Pancreatic cancer microenvironment. Int J Cancer 121: 699-705, 2007. (Pubitemid 47106197)
5. Vega FM and Ridley AJ: Rho GTPases in cancer cell biology. FEBS Lett 582: 2093-2101, 2008.
6. Reymond N, Riou P and Ridley AJ: Rho GTPases and cancer cell transendothelial migration. Methods Mol Biol 827: 123-142, 2012.
7. Garcia-Mata R, Boulter E and Burridge K: The 'invisible hand': regulation of RHO GTPases by RHOGDIs. Nat Rev Mol Cell Biol 12: 493-504, 2011.
8. Scherle P, Behrens T and Staudt LM: Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proc Natl Acad Sci USA 90: 7568-7572, 1993. (Pubitemid 23249991)
9. Cho HJ, Baek KE and Yoo J: RhoGDI2 as a therapeutic target in cancer. Expert Opin Ther Targets 14: 67-75, 2010.
10. Cho HJ, Baek KE, Park SM, et al: RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer. Clin Cancer Res 15: 2612-2619, 2009.
11. Li X, Wang J, Zhang X, Zeng Y, Liang L and Ding Y: Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma. Ann Surg Oncol 19: 145-153, 2012.
12. Zhang Y and Zhang B: D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness. Cancer Res 66: 5592-5598, 2006. (Pubitemid 43927109)
13. Gildea JJ, Seraj MJ, Oxford G, et al: RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 62: 6418-6423, 2002. (Pubitemid 35364098)
14. Ma L, Xu G, Sotnikova A, et al: Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma. Br J Haematol 139: 217-223, 2007. (Pubitemid 47493088)
15. Dransart E, Olofsson B and Cherfils J: RhoGDIs revisited: novel roles in Rho regulation. Traffic 6: 957-966, 2005. (Pubitemid 41472455)
16. Boulter E, Garcia-Mata R, Guilluy C, et al: Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1. Nat Cell Biol 12: 477-483, 2010.
17. Morin A, Cordelières FP, Cherfils J and Olofsson B: RhoGDI3 and RhoG: vesicular trafficking and interactions with the Sec3 exocyst subunit. Small GTPases 1: 142-156, 2010.
18. Lelias JM, Adra CN, Wulf GM, et al: cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins. Proc Natl Acad Sci USA 90: 1479-1483, 1993. (Pubitemid 23058196)
19. Boulter E and Garcia-Mata R: RhoGDI: A rheostat for the Rho switch. Small GTPases 1: 65-68, 2010.
20. Harding MA and Theodorescu D: RhoGDI signaling provides targets for cancer therapy. Eur J Cancer 46: 1252-1259, 2010.
21. Niu H, Li H, Xu C and He P: Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis. Oncol Rep 24: 465-471, 2010.
22. Cho HJ, Baek KE, Kim IK, et al: Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer. J Proteome Res 11: 2355-2364, 2012.
23. Theodorescu D, Sapinoso LM, Conaway MR, Oxford G, Hampton GM and Frierson HF Jr: Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res 10: 3800-3806, 2004. (Pubitemid 38697615)
24. Dovas A and Couchman JR: RhoGDI: multiple functions in the regulation of Rho family GTPase activities. Biochem J 390: 1-9, 2005. (Pubitemid 41192225)
25. DerMardirossian C and Bokoch GM: GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol 15: 356-363, 2005. (Pubitemid 40943524)
26. Hart MJ, Maru Y, Leonard D, Witte ON, Evans T and Cerione RA: A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42Hs. Science 258: 812-815, 1992.
27. Chuang TH, Xu X, Knaus UG, Hart MJ and Bokoch GM: GDP dissociation inhibitor prevents intrinsic and GTPase activating protein-stimulated GTP hydrolysis by the Rac GTP-binding protein. J Biol Chem 268: 775-778, 1993. (Pubitemid 23019701)
28. Schunke D, Span P, Ronneburg H, et al: Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells. Cancer Res 67: 10694-10702, 2007. (Pubitemid 350145895)
29. Cho HJ, Baek KE, Nam IK, et al: PLCã is required for RhoGDI2-mediated cisplatin resistance in gastric cancer. Biochem Biophys Res Commun 414: 575-580, 2011.
30. Friedl P and Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374, 2003. (Pubitemid 37328856)
31. Binker MG, Binker-Cosen AA, Richards D, Oliver B and Cosen-Binker LI: EGF promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and activation of MMP-2. Biochem Biophys Res Commun 379: 445-450, 2009.